The US FDA Grants Marketing Authorization to Virtual Incision’s MIRA Surgical System for Adults Undergoing Colectomy Procedures
Shots:
- The US FDA has authorized the company's MIRA Surgical System (MIRA) for adults undergoing colectomy procedures based on the program conducted across the US. The device’s commercialization will begin through the First Access Program
- The MIRA, a miniature robotic-assisted surgery (miniRAS) device, aims to offer the benefits of robotic surgery without the need to reorganize ORs
- Additionally, the company anticipates the expansion of MIRA’s utility into gynecology, general surgery, urology and other soft tissue & solid organ surgeries. Studies in gynecological procedure are expected in 2024, while a new iteration designed for general surgery is underway, with its FIH study outside the US expected later in 2024
Ref: Virtual Incision | Image: Virtual Incision
Related News:- AM-Pharma Commences P-II Study Evaluating Ilofotase Alfa for Cardiac Surgery-Associated Renal Damage
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
